These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 7843252

  • 1. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Busch R, Vturina IY, Drexler J, Momburg F, Hämmerling GJ.
    Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
    [Abstract] [Full Text] [Related]

  • 2. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C, van Endert P, Koch N.
    J Immunol; 1995 Feb 01; 154(3):1048-56. PubMed ID: 7822782
    [Abstract] [Full Text] [Related]

  • 3. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L, Kovats S, Eastman S, Rudensky AY.
    J Immunol; 1996 Mar 15; 156(6):2196 - 2204. PubMed ID: 8690909
    [Abstract] [Full Text] [Related]

  • 4. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.
    Busch R, Cloutier I, Sékaly RP, Hämmerling GJ.
    EMBO J; 1996 Jan 15; 15(2):418-28. PubMed ID: 8617217
    [Abstract] [Full Text] [Related]

  • 5. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S, Humphreys RE.
    Eur J Immunol; 1995 Jun 15; 25(6):1693-702. PubMed ID: 7614997
    [Abstract] [Full Text] [Related]

  • 6. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL, Smith KD, Lutz CT.
    J Immunol; 1996 Nov 15; 157(10):4503-10. PubMed ID: 8906828
    [Abstract] [Full Text] [Related]

  • 7. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO, LaVaute T, Pinet V, Jaraquemada D.
    J Immunol; 1994 Aug 15; 153(4):1487-94. PubMed ID: 8046228
    [Abstract] [Full Text] [Related]

  • 8. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
    Teyton L, O'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, Peterson PA.
    Nature; 1990 Nov 01; 348(6296):39-44. PubMed ID: 2234057
    [Abstract] [Full Text] [Related]

  • 9. Invariant chain alters the malignant phenotype of MHC class II+ tumor cells.
    Clements VK, Baskar S, Armstrong TD, Ostrand-Rosenberg S.
    J Immunol; 1992 Oct 01; 149(7):2391-6. PubMed ID: 1527384
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L, Perera JD, Boyd LF, Margulies DH, McCluskey J.
    J Immunol; 1990 Apr 15; 144(8):2915-24. PubMed ID: 1969876
    [Abstract] [Full Text] [Related]

  • 16. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K, Miller J.
    J Immunol; 1995 Jul 15; 155(2):630-43. PubMed ID: 7608541
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
    Lamb CA, Cresswell P.
    J Immunol; 1992 Jun 01; 148(11):3478-82. PubMed ID: 1588042
    [Abstract] [Full Text] [Related]

  • 19. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S.
    Eur J Immunol; 1993 Sep 01; 23(9):2100-8. PubMed ID: 8370392
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.